Cigna Group — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 38/100
What the filing says
Cigna Group reported Q2 2026 adjusted income from operations of $2.054 billion ($7.78/share), up 6% YoY, on revenues of $71.668 billion (+7% YoY). The company raised its 2026 full-year adjusted EPS guidance by $0.10 to at least $30.45/share. Evernorth revenues grew 6% but operating income declined 2%; Cigna Healthcare revenues grew 9% with operating income up 17%. Year-to-date through July 29, 2026, the company repurchased 0.9 million shares for ~$250 million. The company also announced its planned exit from Individual and Family Plans medical business effective January 1, 2027.
Why this rating
Modest EPS beat and modest guidance raise on strong topline growth, but offset by strategic retreat (IFP exit) and margin pressure in Evernorth pharmacy—ordinary earnings cycle for $88B company.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.